Healthcare

Healthcare Insights

Latest

Healthcare | Update

Mendus — Steady progress throughout Q225

Healthcare | Spotlight — update

Herantis Pharma — H125 results reflect Phase Ib progress

Healthcare | Flash

Mendus — Clinical activities on track

Healthcare | Update

Immix Biopharma — Fleshing out the CAR-T strategy

insight

Healthcare

An update on OpGen: Deals, expansion and revenues

insight

Healthcare

Volition: Views from the sharp end

Incannex mother and child

insight

Healthcare

Incannex Healthcare: Data opens path to treat anxiety

insight

Healthcare

February 2023 Edition of Edison Healthcare Insight

Equities

KALA BIO (KALA)

Latest price

USD9.21

0.71 (8.35)
As at 22/08/2025
Market capitalisation
USD60m

Medigene (MDG1)

Latest price

EUR0.13

−0.05 (−27.57)
As at 22/08/2025
Market capitalisation
EUR2m

Mendus (IMMU)

Latest price

SEK7.41

0.01 (0.14)
As at 22/08/2025
Market capitalisation
SEK386m
View equity

Newron Pharmaceuticals (NWRN)

Latest price

CHF7.63

−0.17 (−2.18)
As at 22/08/2025
Market capitalisation
CHF140m
View equity

Nykode Therapeutics (NYKD)

Latest price

NOK1.75

0.00 (−0.29)
As at 22/08/2025
Market capitalisation
NOK573m
View equity

Ocugen (OCGN)

Latest price

USD1.01

0.00 (0.00)
As at 22/08/2025
Market capitalisation
USD296m
View equity

Okyo Pharma (OKYO)

Latest price

USD2.37

0.04 (1.72)
As at 22/08/2025
Market capitalisation
USD88m
View equity

Oncopeptides (ONCO)

Latest price

SEK4.19

0.15 (3.72)
As at 22/08/2025
Market capitalisation
SEK853m

OpGen (OPGN)

Latest price

0.00 (0.00)
As at 22/08/2025
Market capitalisation
View equity

Oryzon Genomics (ORY)

Latest price

EUR2.76

0.12 (4.55)
As at 22/08/2025
Market capitalisation
EUR207m
View equity

OSE Immunotherapeutics (OSE)

Latest price

EUR6.32

−0.03 (−0.47)
As at 22/08/2025
Market capitalisation
EUR146m
View equity

Percheron Therapeutics (PER)

Latest price

AUD0.01

0.00 (−9.09)
As at 22/08/2025
Market capitalisation
AUD10m

Recce Pharmaceuticals (RCE)

Latest price

AUD0.42

−0.01 (−2.35)
As at 22/08/2025
Market capitalisation
AUD121m
View equity

Saniona (SANION)

Latest price

SEK11.56

0.02 (0.17)
As at 22/08/2025
Market capitalisation
SEK1,593m
View equity

Santhera Pharmaceuticals (SANN)

Latest price

CHF14.48

0.12 (0.84)
As at 22/08/2025
Market capitalisation
CHF195m

Sareum Holdings (SAR)

Latest price

GBP0.22

−2.00 (−8.33)
As at 22/08/2025
Market capitalisation
GBP33m
View equity

Curated by Edison

The Next Step for AI in Biology Is to Predict How Proteins Behave in the Body - Thumbnail image

singularityhub.com

The Next Step for AI in Biology Is to Predict How Proteins Behave in the Body

Healthcare

A new protein atlas can help turn static AI predictions of protein shapes into more fluid predictions of how proteins behave in the body.

Read article
The Cost of Sequencing a Human Genome - Thumbnail image

www.genome.gov

The Cost of Sequencing a Human Genome

Healthcare

Estimated cost of sequencing the human genome over time since the Human Genome Project.

Read article
J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies - Thumbnail image

www.prnewswire.com

J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies

Healthcare

/PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team...

Read article
Leveraging nanotechnology to transform the disinfection industry - Thumbnail image

insights.omnia-health.com

Leveraging nanotechnology to transform the disinfection industry

Healthcare

Co-founders of Kismet Technologies, Christina Drake and Shari Costantini, discuss how NanoRad, one of their flagship products, uses targeted application to kill a wide range of bacteria and viruses.

Read article
2022 Healthcare Provider IT Report: Post-Pandemic Investment Priorities - Thumbnail image

www.bain.com

2022 Healthcare Provider IT Report: Post-Pandemic Investment Priorities

Healthcare

As healthcare providers enter a new period of disruption, their software investment priorities present opportunities for vendors and investors.

Read article

Thematics

cell DNA double helix

thematic

Healthcare

Cell and gene therapies

thematic

Healthcare

Drug delivery platforms

thematic

Healthcare

Neuroscience comeback

thematic

Consumer

IPO apocalypse

thematic

Healthcare

Oncology ABCs (part two) – vaccines: niche no longer

thematic

TMT

ESG, moving beyond the box tick

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free